x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

DarshanTalks Podcast

Darshan Kulkarni

Welcome to DarshanTalks!We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.We focus on life science issues involving

science life sciences

All Episodes

14:56

Health Tech Startups: From Garage to FDA

DarshanTalks Podcast ·

2026/08/13

Send us Fan Mail Thinking about launching a health tech startup, digital health app, or wearable device? Moving fast and breaking things might work in software, but in healthcare, breaking things means breaking people. In this episode of the KF Deep Dive, host Darshan Kulkarni connects with Emily Hu Shapiro—a Silicon Valley native, chemical/biomedical engineer, former Google clinical research lead, powerlifter, and startup investor—to bust the myth of the solo "garage startup" in medical devi...

en-us

13:54

Is Your Clinical Trial IP Already Leaked?

DarshanTalks Podcast ·

2026/08/06

Send us Fan Mail The wellness industry is undergoing a massive boom, but modern contrast therapy, thermal bathing, and sauna facilities are stepping directly into an unseen legal grid. In this episode of the KF Deep Dive, host Darshan Kulkarni sits down with healthcare regulatory attorney Kate Woods and former public defender turned sauna master McKenzie Bowling to pull back the curtain on the regulatory boundaries of thermal wellness. Together, they explore why saunas remain largely unregula...

en-us

17:53

Decoding Australia's TGA Regulations

DarshanTalks Podcast ·

2026/07/30

Send us Fan Mail Thinking about launching a health product, dietary supplement, or digital health solution in the Australian market? You might want to hit pause before assuming your U.S. or European regulatory strategy will translate. In this episode of the KF Deep Dive, host Daran Carney connects with Isabelle Petour, Principal of Launchpad Regulatory, a boutique regulatory affairs firm based in Sydney. Together, they pull back the curtain on Australia's Therapeutic Goods Administration (TGA...

en-us

15:25

AI "Going Rogue": The Legality of Healthcare Chatbots

DarshanTalks Podcast ·

2026/07/23

Send us Fan Mail What happens when an artificial intelligence chatbot moves past answering basic questions and starts actively pretending to be a licensed psychiatrist? In this episode of the KF Deep Dive, host Daran Carney welcomes premier healthcare regulatory and privacy attorney Elizabeth Litton, Chief Privacy and HIPAA Compliance Officer at Fox Rothschild. Together, they break down the explosive headline triggering shockwaves across the tech and medical industries: Pennsylvania Governor ...

en-us

15:18

Pharmacy's Critical Role in Clinical Trial Compliance

DarshanTalks Podcast ·

2026/07/16

Send us Fan Mail Think clinical trial compliance is just a part-time job or a paperwork exercise that can be passed off to a medical assistant? Think again. In this episode of the KF Deep Dive, host Daran Carney sits down with Tom Sepka, CEO of HCI Healthcare Consultants and veteran Chief Pharmacy Officer, to shatter the myth that research pharmacy oversight is optional. Together, they break down the deep operational complexities of managing investigational drugs—from navigating strict DEA re...

en-us

4:36

The Wild Lizard Venom Origins of Ozempic

DarshanTalks Podcast ·

2026/07/08

Send us Fan Mail How a "Failed" 4-Minute Molecule Created a Trillion-Dollar Cultural Eclipse Imagine pitching a drug to a room of venture capitalists that is biologically perfect—except for one tiny flaw: the human body completely destroys it in four minutes flat. That is the exact garbage hand Danish pharma giant Novo Nordisk was dealt in the 1990s. Today, that exact same molecule is Ozempic and Wegovy, a global phenomenon reshaping culture, tech, Hollywood, and global economies. But how did...

en-us

15:25

Unlicensed Medical Advice & The Legal Battle Over...

DarshanTalks Podcast ·

2026/05/18

Send us Fan Mail What happens when an artificial intelligence chatbot generates a fake medical license number and starts giving psychiatric advice? In this episode of the KF Deep Dive, host Darshan welcomes healthcare regulatory expert and Fox Rothschild Chief Privacy Officer, Elizabeth Litten, to untangle a wild new frontier in legal tech. We break down the historic lawsuit filed by Pennsylvania Governor Josh Shapiro against Character.AI after a companion bot unlawfully held itself out as a ...

en-us

4:47

Sponsoring Cannabis Research

DarshanTalks Podcast ·

2026/05/06

Send us Fan Mail NOT LEGAL ADVICE For decades, cannabis research in the U.S. was stifled by Schedule I restrictions, requiring high-security vaults, mountains of paperwork, and extremely limited supply chains. With Executive Order 14370, the landscape has shifted. Marijuana is moving to Schedule III, and the rules of the game have officially changed. In this episode of KLF Deep Dive, attorney-pharmacist Darshan Kulkarni breaks down the practical impact of this reclassification for...

en-us

8:04

The New Era of Personal Consent Decrees

DarshanTalks Podcast ·

2026/04/30

Send us Fan Mail Is your career protected from your company’s mistakes? For decades, a Federal Consent Decree was a corporate headache. Today, it’s a personal professional death sentence. In this episode, Darshan Kulkarni breaks down the seismic shift in federal enforcement: why agencies are now naming CEOs, CMOs, and Heads of Clinical operations by name in injunctions. We explore the "Delegation Trap," the rise of the Office of Data Reliability, and the KLF Playbook for ensuring your name ne...

en-us

7:03

Why Private Membership Associations Fail FDA Scrutiny

DarshanTalks Podcast ·

2026/04/16

Send us Fan Mail In this episode of the KLF Deep Dive, Darshan Kulkarni deconstructs a persistent and dangerous myth circulating in life sciences and investment circles: the Private Membership Association (PMA). While often marketed as a "contract-based loophole" to evade FDA oversight and civil liability, the reality in federal court is starkly different. Darshan examines the constitutional limits of "freedom of association" and analyzes key case law—including Little v. Q Lasers—to dem...

en-us

7:57

The Hidden Reason Sites are Firing Recruiters

DarshanTalks Podcast ·

2026/04/11

Send us Fan Mail What would happen if your clinical trial sites were suddenly banned from using you? In this episode, Darshan Kulkarni uncovers a hidden regulatory shift: state licensing boards are tightening the "Corporate Practice of Medicine" and "Fee Splitting" laws. If your recruitment fees are tied to enrollment or revenue, you aren't just a vendor—you’re a legal liability. We break down the MSO structures that are failing, the "Red Zones" in state law, and how KLF re-architects y...

en-us

1:06

Don’t Let Your PI Walk Away With Your Study

DarshanTalks Podcast ·

2026/04/10

Send us Fan Mail In this tactical masterclass, Darshan Kulkarni breaks down the critical legal architecture required to protect clinical trial sites during rapid expansion. As PIs and Sub-Investigators move between organizations, the risk of losing proprietary data and patient continuity skyrockets. Learn the specific clauses—from non-solicitation to transition requirements—that ensure your site retains its value and your sponsors remain confident. Don't let your most valuable assets wa...

en-us

2:24

Safe or Just "Not Dirty"? The Regulatory Gamble of...

DarshanTalks Podcast ·

2026/04/09

Send us Fan Mail In this episode, Darshan Kulkarni breaks down the staggering legal difference between the branded drugs you know (like Mounjaro) and the compounded versions flooding the market. Using a brilliant "Coke vs. RC Cola" analogy, we explore why "clean vats" aren't the same as "proven science." If you are a patient, a provider, or a legal professional in the life sciences space, you need to understand the four pillars of FDA approval—and why some of the most popular drugs on t...

en-us

3:51

"Basically Employees" Isn't a Legal Category (And the...

DarshanTalks Podcast ·

2026/04/06

Send us Fan Mail Stop playing compliance theater. In this episode, Darshan Kulkarni pulls back the curtain on a dangerous trend in the life sciences: the over-reliance on contract sales forces without the legal control to back them up. Many companies believe they’ve "solved" the incentive pay problem, only to realize the OIG hasn't changed its mind since 1998. We break down why the "Pikachu face" won't save you when the government comes knocking, the myth of the "basically an employee" legal ...

en-us

0:45

The Hidden Legal Risks of AI Sponsor Protocols

DarshanTalks Podcast ·

2026/04/03

Send us Fan Mail Is AI the savior of clinical research costs, or a ticking time bomb for data integrity? In this episode, Darshan Kulkarni dives into the murky waters of AI-driven sponsor protocols. We explore how AI is being used to mask—and unmask—data falsification, and what life science sponsors must do to ensure compliance before the regulators knock. If you’re using AI to "make life easier," you might be making your legal defense much harder. Support the show www.kulkarnilaw...

en-us

3:26

The $100M Mistake: Why AI-Generated Drugs May Not Be...

DarshanTalks Podcast ·

2026/04/02

Send us Fan Mail "The model said so" is not a defense. In the rush to integrate AI into drug discovery, life science companies are sprinting toward a compliance cliff. In this episode, Darshan Kulkarni—pharmacist and FDA regulatory lawyer—strips away the marketing hype to reveal the "messy reality" of AI in regulated environments. We dive deep into the three pillars of risk that can sink a biotech firm: Data Integrity: Why AI scales bad data faster than you can fix it.The Ownership Crisis: Wh...

en-us

12:57

Is AI replacing your Doctor?

DarshanTalks Podcast ·

2026/03/30

Send us Fan Mail In this episode of DarshanTalks, host and attorney-pharmacist Darshan Kulkarni explores the unsettling transition from "Googling your symptoms" to "Chatting with your symptoms." It’s 10:47 PM—you have chest tightness and a chatbot is your only companion. But is the algorithm reassuring you, or is it gaslighting a medical emergency? We go beyond the hype to examine the February 9, 2026, Nature Medicine study (as reported in the New York Times) which reveals a staggering gap be...

en-us

0:53

Why the OIG Just Revolutionized Pharma Marketing (And...

DarshanTalks Podcast ·

2026/03/28

Send us Fan Mail On January 27, 2026, the HHS Office of Inspector General (OIG) changed the game for pharmaceutical manufacturers. In a landmark Special Advisory Bulletin, the government officially opened a "green lane" for direct-to-patient (DTP) drug sales, specifically addressing the rise of cash-pay programs like TrumpRx. In this episode, we break down why the OIG is now prioritizing lower costs over traditional Anti-Kickback Statute (AKS) risks for cash-paying patients—including th...

en-us

0:42

6 Categories of "Bulk Data" That Could Land You in...

DarshanTalks Podcast ·

2026/03/27

Send us Fan Mail The DOJ just changed the rules of the game for the Life Sciences industry. As of January 2025, transferring "Bulk Sensitive Personal Data" to countries of concern—specifically China—is no longer just a compliance hurdle; it’s a potential federal violation. In this episode, Darshan Kulkarni breaks down the six categories of data you must protect immediately, from genomic data to precise geolocation. If you are handling safety data across borders, this is your mandatory executi...

en-us

1:39

The Utah Experiment: The Dangerous New Frontier of AI...

DarshanTalks Podcast ·

2026/03/26

Send us Fan Mail Is your state "sandbox" a playground or a legal minefield? In this episode, Darshan Kulkarni—pharmacist and attorney—dissects the quiet movement of states like Utah allowing AI to manage and renew prescriptions. While the innovation is exciting, the federal government is watching closely. We break down the three massive risks facing life science companies and healthcare providers today: Clinical Logic Failures: Why a state sandbox can't fix bad AI medicine.The Liability Void:...

en-us

340 results

Similar Podcasts

Realitätstheorie

Benjamin Ewers, Raoul-Amadeus Lorbeer

Sci-Fi Books -Daily

solgoodmedia.com

New Books in Science

New Books Network

Science News Daily

brief.news

DarshanTalks Podcast

Darshan Kulkarni